Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.43 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.43 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.43 |
| ▸ | GABRP | O00591 | 4/20 | 0.43 |
| ▸ | GABRD | O14764 | 4/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.43 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.43 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.43 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.43 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.43 |
| ▸ | GABRA3 | P34903 | 4/20 | 0.43 |
| ▸ | GABRA2 | P47869 | 4/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.43 |
| ▸ | GABRA4 | P48169 | 4/20 | 0.43 |
| ▸ | GABRE | P78334 | 4/20 | 0.43 |
| ▸ | GABRA6 | Q16445 | 4/20 | 0.43 |
| ▸ | GABRG1 | Q8N1C3 | 4/20 | 0.43 |
| ▸ | GABRG3 | Q99928 | 4/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| D-Alanine SCHEMBL2027760 | 1.00 | SLC7A5 (0.59) | SLC7A5TP53SLC1A3SLC1A2SLC1A1 | |
| Alanine SCHEMBL14764702 | 1.00 | SLC7A5 (0.59) | SLC7A5TP53SLC1A3SLC1A2SLC1A1 | |
| D-Alanine SCHEMBL614024 | 1.00 | SLC7A5 (0.59) | SLC7A5TP53SLC1A3SLC1A2SLC1A1 | |
| D-Alanine SCHEMBL43623 | 1.00 | — | — | |
| Alanine SCHEMBL1332110 | 1.00 | — | — | |
| Alanine SCHEMBL254290 | 1.00 | SLC7A5 (0.59) | SLC7A5TP53SLC1A3SLC1A2SLC1A1 | |
| Alanine SCHEMBL31 | 1.00 | — | — | |
| Alanine SCHEMBL2784274 | 1.00 | — | — | |
| Alanine SCHEMBL10723495 | 1.00 | SLC7A5 (0.59) | SLC7A5TP53SLC1A3SLC1A2SLC1A1 | |
| D-Alanine SCHEMBL31040666 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116694539-B | Lactobacillus plantarum J26 as direct vat set starter, and preparation method and application thereof | 东北农业大学 | 2023-11-17 | — | — | CN | disclosed |
| US-10471149-B2 | Stabilized vancomycin formulations | INSMED INCORPORATED (US) | 2019-11-12 | — | — | US | disclosed |
| EP-2925298-B1 | STABILIZED VANCOMYCIN FORMULATIONS | INSMED INC (US) | 2019-05-29 | — | — | EP | disclosed |
| US-20190022232-A1 | STABILIZED VANCOMYCIN FORMULATIONS | INSMED INCORPORATED | 2019-01-24 | — | — | US | disclosed |
| US-10124066-B2 | Stabilized vancomycin formulations | INSMED INCORPORATED (US) | 2018-11-13 | — | — | US | disclosed |
| US-20150314002-A1 | STABILIZED VANCOMYCIN FORMULATIONS | INSMED INCORPORATED | 2015-11-05 | — | — | US | disclosed |
| US-8269037-B2 | Absorption medium for removing acid gases which comprises amino acid and acid promoter | BASF SE (DE) | 2012-09-18 | — | — | US | disclosed |
| EP-2449488-A1 | METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES | BIOCRATES Life Sciences AG (AT) | 2012-05-09 | — | — | EP | disclosed |
| US-20120051989-A1 | REMOVAL OF ACID GASES FROM A FLUID FLOW BY MEANS OF REDUCED COABSORPTION OF HYDROCARBONS AND OXYGEN | BASF SE (DE) | 2012-03-01 | — | — | US | disclosed |
| US-8034166-B2 | Carbon dioxide absorbent requiring less regeneration energy | BASF SE (DE) | 2011-10-11 | — | — | US | disclosed |
| WO-1998046631-A1 | COMBINATORIAL LIBRARIES OF PEPTIDOMIMETIC MACROCYCLES AND PROCESSES THEREFOR | ELI LILLY AND COMPANY (US) | 1998-10-22 | — | — | WO | disclosed |
| WO-1998046786-A1 | COMBINATORIAL LIBRARIES OF PEPTIDOMIMETIC AMINOTHIOETHER ACIDS | ELI LILLY AND COMPANY (US) | 1998-10-22 | — | — | WO | disclosed |
| US-5478733-A | Culture product | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1995-12-26 | — | — | US | disclosed |
| US-5403579-A | A mouthwashes consisting of a higher alkyl-N-sulfobetaine and a higher alkyl dimethylamine oxide, dihydroxyethylamine oxide or acylamide tert-amine oxide; antibacteria, antiplague, antistaining | E. B. MICHAELS RESEARCH ASSOCIATES, INC. (US) | 1995-04-04 | — | — | US | disclosed |
| EP-0294391-B1 | PROCESS AND COMPOSITION FOR ORAL HYGIENE | MICHAELS E B RES ASS (US) | 1994-02-02 | — | — | EP | disclosed |
| US-5275804-A | Amphoteric surfactants as bactericides or fungicides for mouth washes | E. B. MICHAELS RESEARCH ASSOCIATES, INC. (US) | 1994-01-04 | — | — | US | disclosed |
| EP-0294391-A4 | PROCESS AND COMPOSITION FOR ORAL HYGIENE | — | 1991-10-16 | — | — | EP | disclosed |
| US-4839158-A | APPLYING MIXTURES OF HIGHER ALKYL N-BETAINE AND N,N-DIMETHYL AMINE OXIDE | E. B. MICHAELS RESEARCH ASSOCIATES INC. (US) | 1989-06-13 | — | — | US | disclosed |
| EP-0294391-A1 | PROCESS AND COMPOSITION FOR ORAL HYGIENE. | MICHAELS E B RES ASS INC (US) | 1988-12-14 | — | — | EP | disclosed |
| WO-1987004922-A1 | PROCESS AND COMPOSITION FOR ORAL HYGIENE | E.B. MICHAELS RESEARCH ASSOCIATES, INC. (US) | 1987-08-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10471149-B2 | Stabilized vancomycin formulations | CETP, PCSK9, HDLBP | SLC7A5 1112/4885TP53 2076/4885SLC1A3 3544/4885 |
| US-10124066-B2 | Stabilized vancomycin formulations | CETP, PCSK9, HDLBP | SLC7A5 1112/4885TP53 2076/4885SLC1A3 3544/4885 |
| US-20150314002-A1 | STABILIZED VANCOMYCIN FORMULATIONS | CETP, PCSK9, HDLBP | SLC7A5 1112/4885TP53 2076/4885SLC1A3 3544/4885 |
| US-20190022232-A1 | STABILIZED VANCOMYCIN FORMULATIONS | CETP, PCSK9, HDLBP | SLC7A5 1112/4885TP53 2076/4885SLC1A3 3544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.